MedTrace Logo

Autonomic Nervous System and Sickle Cell Disease

NCT04062409 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2023-02-03

No results posted yet for this study

Summary

Sickle cell disease (SCD) children and adults with asthma have an increased rate of vaso-occlusive crisis, acute chest syndrome episodes, and premature mortality when compared to those without asthma. We hypothesised that either asthma diagnosis and/or bronchodilator treatment may aggravate SCD via their modulating effect on autonomic nervous system.

Conditions

  • Heart Rate Variability (ANS Function)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Christophe Delclaux, MD PhD · APHP

Eligibility

Min Age
6 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-05
Primary Completion
2019-04-15
Completion
2019-05-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04062409 on ClinicalTrials.gov